Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014.

Miglietta A, Quinten C, Lopalco PL, Duffell E.

Euro Surveill. 2018 Feb;23(6). doi: 10.2807/1560-7917.ES.2018.23.6.17-00278.

2.

Health literacy, emotionality, scientific evidence: Elements of an effective communication in public health.

Biasio LR, Carducci A, Fara GM, Giammanco G, Lopalco PL.

Hum Vaccin Immunother. 2018 Jan 30:1-2. doi: 10.1080/21645515.2018.1434382. [Epub ahead of print]

PMID:
29381399
3.

Safety of HPV vaccines in the age of nonavalent vaccination.

Quattrone F, Canale A, Filippetti E, Tulipani A, Porretta A, Lopalco PL.

Minerva Pediatr. 2018 Feb;70(1):59-66. doi: 10.23736/S0026-4946.17.05147-7.

PMID:
29363293
4.

Overcoming barriers in HPV vaccination and screening programs.

Vorsters A, Arbyn M, Baay M, Bosch X, de Sanjosé S, Hanley S, Karafillakis E, Lopalco PL, Pollock KG, Yarwood J, Van Damme P.

Papillomavirus Res. 2017 Dec;4:45-53. doi: 10.1016/j.pvr.2017.07.001. Epub 2017 Jul 20.

5.

Resurgence of Pertussis and Emergence of the Ptxp3 Toxin Promoter Allele in South Italy.

Loconsole D, De Robertis AL, Morea A, Metallo A, Lopalco PL, Chironna M.

Pediatr Infect Dis J. 2018 May;37(5):e126-e131. doi: 10.1097/INF.0000000000001804.

PMID:
28945679
6.

Detection of viable but non-culturable legionella in hospital water network following monochloramine disinfection.

Casini B, Baggiani A, Totaro M, Mansi A, Costa AL, Aquino F, Miccoli M, Valentini P, Bruschi F, Lopalco PL, Privitera G.

J Hosp Infect. 2018 Jan;98(1):46-52. doi: 10.1016/j.jhin.2017.09.006. Epub 2017 Sep 13.

PMID:
28917570
7.

A nosocomial measles outbreak in Italy, February-April 2017.

Porretta A, Quattrone F, Aquino F, Pieve G, Bruni B, Gemignani G, Vatteroni ML, Pistello M, Privitera GP, Lopalco PL.

Euro Surveill. 2017 Aug 17;22(33). pii: 30597. doi: 10.2807/1560-7917.ES.2017.22.33.30597.

8.

Corrigendum to "Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV".

Di Mario S, Basevi V, Lopalco PL, Balduzzi S, D'Amico R, Magrini N.

J Immunol Res. 2017;2017:4583487. doi: 10.1155/2017/4583487. Epub 2017 May 30.

9.

The web and public confidence in MMR vaccination in Italy.

Aquino F, Donzelli G, De Franco E, Privitera G, Lopalco PL, Carducci A.

Vaccine. 2017 Aug 16;35(35 Pt B):4494-4498. doi: 10.1016/j.vaccine.2017.07.029. Epub 2017 Jul 20.

PMID:
28736200
10.

Evaluation and control of microbial and chemical contamination in dialysis water plants of Italian nephrology wards.

Totaro M, Casini B, Valentini P, Miccoli M, Giorgi S, Porretta A, Privitera G, Lopalco PL, Baggiani A.

J Hosp Infect. 2017 Oct;97(2):169-174. doi: 10.1016/j.jhin.2017.05.011. Epub 2017 May 22.

PMID:
28546028
11.

Unplanned readmissions within 30 days after discharge: improving quality through easy prediction.

Casalini F, Salvetti S, Memmini S, Lucaccini E, Massimetti G, Lopalco PL, Privitera GP.

Int J Qual Health Care. 2017 Apr 1;29(2):256-261. doi: 10.1093/intqhc/mzx011.

PMID:
28453826
12.

Spotlight on the 9-valent HPV vaccine.

Lopalco PL.

Drug Des Devel Ther. 2016 Dec 20;11:35-44. doi: 10.2147/DDDT.S91018. eCollection 2017. Review.

13.

Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.

Lopalco PL.

Epidemiol Infect. 2017 Feb;145(3):413-419. doi: 10.1017/S0950268816002569. Epub 2016 Nov 21. Review.

PMID:
27866483
14.

The role of surveillance in assuring mutual protection for vaccine-preventable diseases.

Lopalco PL.

Clin Microbiol Infect. 2016 Dec 1;22 Suppl 5:S85-S88. doi: 10.1016/j.cmi.2016.03.019. Epub 2016 Jul 29.

15.
16.

Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Esposito S, Bonanni P, Maggi S, Tan L, Ansaldi F, Lopalco PL, Dagan R, Michel JP, van Damme P, Gaillat J, Prymula R, Vesikari T, Mussini C, Frank U, Osterhaus A, Celentano LP, Rossi M, Guercio V, Gavazzi G.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1777-94. doi: 10.1080/21645515.2016.1150396. Epub 2016 May 2. Review.

17.

Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV.

Di Mario S, Basevi V, Lopalco PL, Balduzzi S, D'Amico R, Magrini N.

J Immunol Res. 2015;2015:435141. doi: 10.1155/2015/435141. Epub 2015 Aug 25. Review. Erratum in: J Immunol Res. 2017;2017:4583487.

18.

Hepatitis A outbreaks.

Severi E, Vennema H, Takkinen J, Lopalco PL, Coulombier D.

Lancet Infect Dis. 2015 Jun;15(6):632-4. doi: 10.1016/S1473-3099(15)00021-3. Epub 2015 May 17. No abstract available.

PMID:
26008835
19.

Is EU/EEA population protected from polio?

Nijsten D, Carrillo-Santisteve P, Miglietta A, Ruitenberg J, Lopalco PL.

Hum Vaccin Immunother. 2015;11(9):2123-31. doi: 10.1080/21645515.2015.1016673. Epub 2015 Apr 21. Review.

20.

Risk factors for death from invasive pneumococcal disease, Europe, 2010.

Navarro-Torné A, Dias JG, Hruba F, Lopalco PL, Pastore-Celentano L, Gauci AJ; Invasive Pneumococcal Disease Study Group.

Emerg Infect Dis. 2015 Mar;21(3):417-25. doi: 10.3201/eid2103.140634.

21.

Safety of human papillomavirus vaccines: a review.

Stillo M, Carrillo Santisteve P, Lopalco PL.

Expert Opin Drug Saf. 2015 May;14(5):697-712. doi: 10.1517/14740338.2015.1013532. Epub 2015 Feb 18. Review.

22.

The complementary roles of Phase 3 trials and post-licensure surveillance in the evaluation of new vaccines.

Lopalco PL, DeStefano F.

Vaccine. 2015 Mar 24;33(13):1541-8. doi: 10.1016/j.vaccine.2014.10.047. Epub 2014 Nov 4. Review.

23.

European enhanced surveillance of invasive pneumococcal disease in 2010: data from 26 European countries in the post-heptavalent conjugate vaccine era.

Navarro Torné A, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJ, Pastore-Celentano L; ECDC country experts for pneumococcal disease.

Vaccine. 2014 Jun 17;32(29):3644-50. doi: 10.1016/j.vaccine.2014.04.066. Epub 2014 May 2.

PMID:
24795228
24.

Varicella vaccination: a laboured take-off.

Carrillo-Santisteve P, Lopalco PL.

Clin Microbiol Infect. 2014 May;20 Suppl 5:86-91. doi: 10.1111/1469-0691.12580. Review.

25.

Vaccine-preventable diseases: the role of the European Centre for Disease Prevention and Control.

Kramarz P, Lopalco PL, Huitric E, Pastore Celentano L.

Clin Microbiol Infect. 2014 May;20 Suppl 5:2-6. doi: 10.1111/1469-0691.12430. Epub 2014 Jan 20. Review.

26.

The issue of mandatory vaccination for healthcare workers in Europe.

Galanakis E, D'Ancona F, Jansen A, Lopalco PL; VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points.

Expert Rev Vaccines. 2014 Feb;13(2):277-83. doi: 10.1586/14760584.2014.869174. Epub 2013 Dec 18. Review.

PMID:
24350731
27.

Actual immunization coverage throughout Europe: are existing data sufficient?

Lopalco PL, Carrillo Santisteve P.

Clin Microbiol Infect. 2014 May;20 Suppl 5:7-11. doi: 10.1111/1469-0691.12453. Epub 2014 Jan 20. Review.

28.

Polio and the risk for the European Union.

Celentano LP, Lopalco PL, Huitric E, Coulombier D, Giesecke J.

Lancet. 2014 Jan 18;383(9913):216-7. doi: 10.1016/S0140-6736(13)62223-0. Epub 2013 Nov 14. No abstract available.

PMID:
24239251
29.

Ethics of mandatory vaccination for healthcare workers.

Galanakis E, Jansen A, Lopalco PL, Giesecke J.

Euro Surveill. 2013 Nov 7;18(45):20627. Review.

30.

Measles still spreads in Europe: who is responsible for the failure to vaccinate?

Carrillo-Santisteve P, Lopalco PL.

Clin Microbiol Infect. 2012 Oct;18 Suppl 5:50-6. doi: 10.1111/j.1469-0691.2012.03982.x. Epub 2012 Aug 27. Review.

31.

Healthcare workers role in keeping MMR vaccination uptake high in Europe: a review of evidence.

Simone B, Carrillo-Santisteve P, Lopalco PL.

Euro Surveill. 2012 Jun 28;17(26). pii: 20206. Review.

32.

Mandatory and recommended vaccination in the EU, Iceland and Norway: results of the VENICE 2010 survey on the ways of implementing national vaccination programmes.

Haverkate M, D'Ancona F, Giambi C, Johansen K, Lopalco PL, Cozza V, Appelgren E; VENICE project gatekeepers and contact points.

Euro Surveill. 2012 May 31;17(22). pii: 20183.

33.

Immunisation registers--important for vaccinated individuals, vaccinators and public health.

Johansen K, Lopalco PL, Giesecke J.

Euro Surveill. 2012 Apr 19;17(16). pii: 20151. No abstract available.

34.

Letter to the editor: commitment needed for the prevention of congenital rubella syndrome in Europe.

Derrough T, Bacci S, Lopalco PL.

Euro Surveill. 2012 Mar 8;17(10). pii: 20106. No abstract available.

35.

Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe.

Mereckiene J, Cotter S, Weber JT, Nicoll A, D'Ancona F, Lopalco PL, Johansen K, Wasley AM, Jorgensen P, Lévy-Bruhl D, Giambi C, Stefanoff P, Dematte L, O'Flanagan D; VENICE project gatekeepers group.

Euro Surveill. 2012 Jan 26;17(4). pii: 20064.

36.

The importance of influenza prevention for public health.

Carrillo-Santisteve P, Ciancio BC, Nicoll A, Lopalco PL.

Hum Vaccin Immunother. 2012 Jan;8(1):89-95. doi: 10.4161/hv.8.1.19066. Epub 2012 Jan 1. Review.

PMID:
22251992
37.

Do European doctors support measles, mumps, rubella vaccination programmes enough?

Lopalco P, Sprenger M.

Euro Surveill. 2011 Sep 29;16(39). pii: 19979. No abstract available.

38.

Assessing vaccination coverage in the European Union: is it still a challenge?

Haverkate M, D'Ancona F, Johansen K, van der Velden K, Giesecke J, Lopalco PL.

Expert Rev Vaccines. 2011 Aug;10(8):1195-205. doi: 10.1586/erv.11.87. Review.

PMID:
21854312
39.

Sudden unexpected deaths and vaccinations during the first two years of life in Italy: a case series study.

Traversa G, Spila-Alegiani S, Bianchi C, Ciofi degli Atti M, Frova L, Massari M, Raschetti R, Salmaso S, Scalia Tomba G; Hera Study Group.

PLoS One. 2011 Jan 26;6(1):e16363. doi: 10.1371/journal.pone.0016363.

40.

Eurogin 2010 roadmap on cervical cancer prevention.

Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM.

Int J Cancer. 2011 Jun 15;128(12):2765-74. doi: 10.1002/ijc.25915. Epub 2011 Mar 25. Review.

41.

Spotlight on measles 2010: measles elimination in Europe - a new commitment to meet the goal by 2015.

Steffens I, Martin R, Lopalco P.

Euro Surveill. 2010 Dec 16;15(50). pii: 19749. No abstract available. Erratum in: Euro Surveill. 2011;16(7). pii: 19794.

42.

Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations.

Stefanoff P, Polkowska A, Giambi C, Levy-Bruhl D, O'Flanagan D, Dematte L, Lopalco PL, Mereckiene J, Johansen K, D'Ancona F; VENICE project gatekeepers, contact persons group.

Vaccine. 2011 Feb 1;29(6):1283-8. doi: 10.1016/j.vaccine.2010.11.077. Epub 2010 Dec 9.

PMID:
21145914
43.

The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.

Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O'Flanagan D, Lopalco PL, D'Ancona F, Levy-Bruhl D; VENICE 2 project gatekeepers group.

Euro Surveill. 2010 Nov 25;15(47). pii: 19730.

44.

Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009.

Mereckiene J, Cotter S, D'Ancona F, Giambi C, Nicoll A, Levy-Bruhl D, Lopalco PL, Weber JT, Johansen K, Dematte L, Salmaso S, Stefanoff P, Greco D, Dorleans F, Polkowska A, O'Flanagan D; VENICE project gatekeepers group.

Euro Surveill. 2010 Nov 4;15(44). pii: 19700.

45.

Childhood pneumococcal vaccination in Europe.

Lopalco PL.

J Prev Med Hyg. 2009 Dec;50(4):197-200. Review. No abstract available.

PMID:
20812513
46.

Control of hepatitis A by universal vaccination of children and adolescents: an achieved goal or a deferred appointment?

Martinelli D, Bitetto I, Tafuri S, Lopalco PL, Mininni RM, Prato R.

Vaccine. 2010 Sep 24;28(41):6783-8. doi: 10.1016/j.vaccine.2010.07.069. Epub 2010 Aug 3.

PMID:
20688041
47.

Measles still spreads in Europe: who is responsible for the failure to vaccinate?

Lopalco PL, Martin R.

Euro Surveill. 2010 Apr 29;15(17). pii: 19557. No abstract available.

48.

Malignant cancer mortality in Province of Taranto (Italy). Geographic analysis in an area of high environmental risk.

Martinelli D, Mincuzzi A, Minerba S, Tafuri S, Conversano M, Caputi G, Lopalco PL, Quarto M, Germinario C, Prato R.

J Prev Med Hyg. 2009 Sep;50(3):181-90.

PMID:
20411653
49.

Monitoring and assessing vaccine safety: a European perspective.

Lopalco PL, Johansen K, Ciancio B, De Carvalho Gomes H, Kramarz P, Giesecke J.

Expert Rev Vaccines. 2010 Apr;9(4):371-80. doi: 10.1586/erv.10.20. Review.

PMID:
20370548
50.

Supplemental Content

Loading ...
Support Center